Dr. Dennis Adeegbe obtained his Ph.D. in Immunology at the University of Miami, where his research focused on immune tolerance in the context of autoimmunity and transplantation tolerance. Supported by the Japanese Society for the Promotion of Science, he completed a postdoctoral fellowship in the lab of Shimon Sakaguchi, from where his research in Immuno-Oncology began. He subsequently joined the Dana-Farber Cancer Institute as a post-doctoral research fellow where his training and research experiences involved translational studies in lung cancer under the supervision of Dr. Kwok-Kin Wong. Dr. Adeegbe is currently a member of the faculty in the Department of Immunology within the H. Lee Moffitt Cancer Center, where he is directing an independent research team focused on tumor immunology and immunotherapy, while contributing to collaborative studies aimed at finding cures for cancer.
Jon Semidey-Hurtado is a Research Associate I in Dr. Adeegbe’s Immunology Research Laboratory at Moffitt Cancer Center. He is a graduate of the University of South Florida with a B.S. in Cell, Molecular, and Microbiology and recently completed his M.S. in Biotechnology at the University of South Florida Morsani College of Medicine. Jon has previous experience in cancer research, studying the effects of the tumor suppressor gene PTEN (Phosphatase and tensin homolog) and its role in the development of lung cancer. Jon plans on continuing in cancer research and is keen to progress in the oncology field.
Po-Jung (Roger) Lin is a Research Associate I in Dr. Adeegbe’s Immunology Research Laboratory at Moffitt Cancer Center. He earned his bioscience degrees in Taiwan and in the U.S. at the University of South Florida. The majority of his research background revolved around cell therapy and animal surgery. For exploring the horizon in the biomedical field, he joined the Immunology research family at Moffitt Cancer Center and applies new techniques combined with his expansive scientific background.
David Noyes has a B.S. in Marine Science, leading to a research technician position in the Center for Shark Research at Mote Marine Laboratory for 5 years, primarily studying shark immune systems. Dave came to Moffitt Cancer Center in 2003, where he has been working in labs that develop therapeutic cancer vaccines and immunotherapies. Dave earned a M.S. in Medical Sciences from USF College of Medicine in 2008.
Catherine Reyes is a Grants Administrator Associate in the Basic Science Department at Moffitt Cancer Center. She is an Assistant to Dennis Adeegbe, an Assistant Member of the Department of Immunology. She is also an Assistant to Jiandong Chen, a Senior Member of the Department of Molecular Oncology, Gary Reuther, an Associate Member of the Department of Molecular Oncology, and Paulo Rodriguez, an Associate Member of the Department of Immunology.
Wael Gamal is a PhD student in the Biomedical Sciences Program at the University of South Florida. He is currently performing his PhD rotation in Dr. Adeegbe's Immunology Research Lab until Mid-February 2019. Wael earned his Bachelor’s and Master’s degrees in Pharmaceutical Sciences from Cairo University in Egypt. He has a previous research experience in the field of vaccine formulation development and immune response evaluation using mouse models. Wael’s passion for cancer immunotherapy encouraged him to pursue his PhD research at Moffitt Cancer Center. His research in Dr. Adeegbe’s lab will be focusing on the role of regulatory T cells in solid cancers like lung cancer and melanoma for understanding the correlation between these immune suppressive cells and other components of the immune system.
Andrew Schultz completed a B.S. in Microbiology & Cell Science with a minor in Music Performance and a M.P.H. in Epidemiology from the University of Florida. Andrew is currently enrolled in the M.P.S. – Data Analytics program at the World Campus of the Pennsylvania State University. Andrew has previous experience working with the vaccinia virus, the first vaccine that was used to eliminate smallpox, and multiple pathogenic bacteria, with a few implicated in the development of cancer. Also, he has experience examining the interconnectedness of the immune system, genetics and potential confounding variables of the peripheral blood and tissues from human organ donors in the context of autoimmunity (type 1 diabetes). Andrew plans on applying his past experiences to systematically contribute to the advancement of cancer research through creativity and collaboration.